Trial Search Results
A Novel Noninvasive Thermoregulatory Device for Postural Tachycardia Syndrome
The investigators hope to learn the feasibility and preliminary efficacy of the Embr device for improving thermal comfort in individuals with POTS and impaired thermoregulation. Feasibility will be assessed via usage of the Embr device and participant feedback. Preliminary efficacy measures will include temperature-related symptoms and temperature- related quality of life in individuals with POTS and impaired thermoregulation.
Stanford is currently not accepting patients for this trial.
Collaborator: Embr Labs, Inc.
- Device: Embr Device
- Diagnosis of POTS
- Participant self-report of heat or cold intolerance
- Willingness to wear the Embr device for 3 weeks, charging the device daily, and
- Have a working smartphone (iPhone 6 or greater; or Android 8.0 or greater
- Comfortable downloading and using the companion app on their phone
- Able to provide informed written consent
- Able to complete written questionnaires
- Prior or current use of the study device
- Hypohidrosis, hyperhidrosis, or anhidrosis, as determined by sudomotor testing;
peripheral neuropathy; perimenopausal, menopausal, postmenopausal state; temperature
intolerance due to other medical disorders (i.e. malignancy, systemic autoimmune
- Medications known to affect sweat function
- Non-English speaking
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study